title: Off-label use of recombinant factor VIIa: why we need better drug monitoring.
authors.affiliation: Ottawa Hospital Research Institute, Department of Medicine, University of Ottawa, Ottawa, Ont., Canada. paul.hebert@cmaj.ca
authors.forename: Paul C
authors.initials: PC
authors.lastname: Hébert
authors.forename: Dean
authors.initials: D
authors.lastname: Fergusson
authors.forename: Matthew B
authors.initials: MB
authors.lastname: Stanbrook
mesh_terms: D016903:Drug Monitoring; D015942:Factor VIIa / Q000627:therapeutic use*; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D056687:Off-Label Use; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa